Vaxcyte, Inc. (PCVX) Q4 2025 Earnings Call Transcript
Source: SeekingAlpha
2026-02-24 23:27:52 ET
Vaxcyte, Inc. (PCVX) Q4 2025 Earnings Call February 24, 2026 4:30 PM EST
Company Participants
Andrew Guggenhime - President & CFO
Grant Pickering - Co-Founder, CEO & Director
James Wassil - Executive VP & COO
Mike Mullette - Chief Commercial Officer
...
Read the full article on Seeking Alpha
For further details see:
Vaxcyte, Inc. (PCVX) Q4 2025 Earnings Call Transcript
Vaxcyte Inc.
NASDAQ: PCVX
PCVX Trading
-2.13% G/L:
$56.97 Last:
436,950 Volume:
$58.13 Open:
PCVX Latest News
June 02, 2026 04:05:00 pm
Vaxcyte Doses First Participant in Phase 1 Study Evaluating VAX-A1 for the Prevention of Disease Caused by Group A Streptococcus in Healthy Adults
May 06, 2026 04:05:00 pm
Vaxcyte Reports First Quarter 2026 Financial Results and Provides Business Update
April 07, 2026 04:05:00 pm
Vaxcyte to Present at the 25th Annual Needham Virtual Healthcare Conference
$7,801,730,421
136,657,209
0.01%
97
N/A
Biotechnology & Life Sciences
Healthcare
US
San Carlos
